Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 2
2009 1
2010 1
2011 3
2012 4
2013 7
2014 12
2015 10
2016 7
2017 11
2018 7
2019 4
2020 8
2021 4
2022 5
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer.
Chi KN, Agarwal N, Bjartell A, Chung BH, Pereira de Santana Gomes AJ, Given R, Juárez Soto Á, Merseburger AS, Özgüroğlu M, Uemura H, Ye D, Deprince K, Naini V, Li J, Cheng S, Yu MK, Zhang K, Larsen JS, McCarthy S, Chowdhury S; TITAN Investigators. Chi KN, et al. N Engl J Med. 2019 Jul 4;381(1):13-24. doi: 10.1056/NEJMoa1903307. Epub 2019 May 31. N Engl J Med. 2019. PMID: 31150574 Free article. Clinical Trial.
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
Smith MR, Saad F, Chowdhury S, Oudard S, Hadaschik BA, Graff JN, Olmos D, Mainwaring PN, Lee JY, Uemura H, Lopez-Gitlitz A, Trudel GC, Espina BM, Shu Y, Park YC, Rackoff WR, Yu MK, Small EJ; SPARTAN Investigators. Smith MR, et al. N Engl J Med. 2018 Apr 12;378(15):1408-1418. doi: 10.1056/NEJMoa1715546. Epub 2018 Feb 8. N Engl J Med. 2018. PMID: 29420164 Free article. Clinical Trial.
Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer.
Sternberg CN, Fizazi K, Saad F, Shore ND, De Giorgi U, Penson DF, Ferreira U, Efstathiou E, Madziarska K, Kolinsky MP, Cubero DIG, Noerby B, Zohren F, Lin X, Modelska K, Sugg J, Steinberg J, Hussain M; PROSPER Investigators. Sternberg CN, et al. N Engl J Med. 2020 Jun 4;382(23):2197-2206. doi: 10.1056/NEJMoa2003892. Epub 2020 May 29. N Engl J Med. 2020. PMID: 32469184 Clinical Trial.
An update on enzalutamide in the treatment of prostate cancer.
Merseburger AS, Haas GP, von Klot CA. Merseburger AS, et al. Among authors: von klot ca. Ther Adv Urol. 2015 Feb;7(1):9-21. doi: 10.1177/1756287214555336. Ther Adv Urol. 2015. PMID: 25642291 Free PMC article. Review.
[Castration resistant prostate cancer 2015].
Merseburger AS, Böker A, Kuczyk MA, von Klot CA. Merseburger AS, et al. Among authors: von klot ca. Aktuelle Urol. 2015 Jan;46(1):59-65. doi: 10.1055/s-0034-1395655. Epub 2015 Feb 6. Aktuelle Urol. 2015. PMID: 25658232 Review. German.
Urinary tract injuries in patients with multiple trauma.
Tezval H, Tezval M, von Klot C, Herrmann TR, Dresing K, Jonas U, Burchardt M. Tezval H, et al. Among authors: von klot c. World J Urol. 2007 Apr;25(2):177-84. doi: 10.1007/s00345-007-0154-y. Epub 2007 Mar 10. World J Urol. 2007. PMID: 17351781 Review.
[Systemic therapy for metastatic renal cell carcinoma].
Kramer MW, Steffens S, von Klot C, Merseburger AS, Kuczyk MA. Kramer MW, et al. Among authors: von klot c. Aktuelle Urol. 2012 Jul;43(4):265-8. doi: 10.1055/s-0032-1321858. Epub 2012 Aug 6. Aktuelle Urol. 2012. PMID: 22869498 Review. German.
Is there an anti-androgen withdrawal syndrome for enzalutamide?
von Klot CA, Kramer MW, Böker A, Herrmann TR, Peters I, Kuczyk MA, Ligges U, Gschwend JE, Retz M, Schmid SC, Stenzl A, Schwentner C, Todenhöfer T, Stöckle M, Ohlmann CH, Azone I, Mager R, Bartsch G, Haferkamp A, Heidenreich A, Piper C, Merseburger AS. von Klot CA, et al. World J Urol. 2014 Oct;32(5):1171-6. doi: 10.1007/s00345-014-1288-3. Epub 2014 Apr 2. World J Urol. 2014. PMID: 24691670
77 results